Paper28428107
Clinicopathological factors associated with survival in patients with breast cancer brain metastasis.
Li R and 3 others. Hum Pathol, 2017. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Clinicopathological factors associated with survival in patients with breast cancer brain metastasis. Papers, record 28428107. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28428107
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clinicopathological factors associated with survival in patients with breast cancer brain metastasis.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone Neoplasms | Major topic |
| Brain Neoplasms | Major topic |
| Breast Neoplasms | Major topic |
| Carcinoma, Lobular | Major topic |
| Adult | |
| Biomarkers, Tumor | |
| Biopsy | |
| Disease-Free Survival | |
| Humans | |
| Immunohistochemistry | |
| Kaplan-Meier Estimate | |
| Middle Aged | |
| Neoplasm Grading | |
| Neoplasm Staging | |
| Predictive Value of Tests | |
| Proportional Hazards Models | |
| Registries | |
| Retrospective Studies | |
| Risk Assessment | |
| Risk Factors | |
| Time Factors |
Source PubMed
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 28655637 | Clinical and pathological factors related to brain relapse-free survival in breast cancer patients. | https://conductscience.org/library/papers/28655637 | PubMed |
| Comment in | 28655640 | Clinical and pathological factors related to brain relapse-free survival in breast cancer patients-reply. | https://conductscience.org/library/papers/28655640 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42038143 | Frequency Survey of Brain Metastases and Its Associated Factors Among Iranian Women with Breast Cancer: A Cross-sectional Study in Tehran City. | Galen Med J | 2024 | https://conductscience.org/library/papers/42038143 | PubMed |
| 40303621 | Investigation of Prevalence, Survival, and Molecular Type of Breast Cancer Patients with Brain Metastases. | Adv Biomed Res | 2025 | https://conductscience.org/library/papers/40303621 | PubMed |
| 40098698 | Developing a predictive model and uncovering immune influences on prognosis for brain metastasis from lung carcinomas. | Front Oncol | 2025 | https://conductscience.org/library/papers/40098698 | PubMed |
| 38683296 | Clinico-pathologic factors and survival of patients with breast cancer diagnosed with de novo brain metastasis: a national cancer database analysis. | Breast Cancer Res Treat | 2024 | https://conductscience.org/library/papers/38683296 | PubMed |
| 36938678 | LINC00460 Facilitates Cell Proliferation and Inhibits Ferroptosis in Breast Cancer Through the miR-320a/MAL2 Axis. | Technol Cancer Res Treat | 2023 | https://conductscience.org/library/papers/36938678 | PubMed |
| 35477385 | Prognosis of lung cancer with simple brain metastasis patients and establishment of survival prediction models: a study based on real events. | BMC Pulm Med | 2022 | https://conductscience.org/library/papers/35477385 | PubMed |
| 35117587 | The effect of metastasis patterns on survival in male patients with different breast cancer subtypes: results from the Surveillance, Epidemiology, and End Results (SEER) database. | Transl Cancer Res | 2020 | https://conductscience.org/library/papers/35117587 | PubMed |
| 32990026 | A view on the landscape of breast cancer brain metastases. | CNS Oncol | 2020 | https://conductscience.org/library/papers/32990026 | PubMed |
| 32309214 | Analysis of Prognostic Factors Affecting the Brain Metastases Free Survival and Survival After Brain Metastases in Breast Cancer. | Front Oncol | 2020 | https://conductscience.org/library/papers/32309214 | PubMed |
| 32110283 | Risk factors for breast cancer brain metastases: a systematic review. | Oncotarget | 2020 | https://conductscience.org/library/papers/32110283 | PubMed |
| 31632048 | Investigation of Prognostic Factors of Survival in Breast Cancer Using a Frailty Model: A Multicenter Study. | Breast Cancer (Auckl) | 2019 | https://conductscience.org/library/papers/31632048 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28428107
GET https://conductscience.org/api/papers/v1/28428107/authors